Support chat
Start a conversation with support.
No messages yet. Send details and an agent will respond. If unavailable, email support@copperstateresearch.local.
Image shown is for reference only. Actual packaging may vary.
Research Use Only — Not for Human Consumption
• Composition and format
Methblue (25 mg) / Methylliberine (50 mg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 25 mg of methylene blue and 50 mg of methylliberine, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details active-component identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
Methblue (25 mg) / Methylliberine (50 mg) is evaluated in controlled in-vitro systems interrogating mitochondrial redox cycling, electron-transport-associated pathways, and neuroactive signaling models, including studies of monoamine- and adenosine-associated mechanisms under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This combination of methylene blue and methylliberine is characterized for use as a multi-analyte research tool in analytical and cell-based models examining redox modulation, cellular energy-related signaling, and neurochemical pathway mapping. In defined in-vitro environments, researchers employ the formulation to study electron-transfer dynamics, changes in cellular redox state, receptor- and transporter-level responses, second-messenger generation, and interaction networks between redox-active and neuroactive systems. Representative applications include assay development, comparative profiling of concentration-response relationships, time-course analyses, and mechanistic studies of mitochondrial and signaling-pathway behavior strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
$200.00
The products listed on this page are intended solely for research use only (RUO). They have not been evaluated by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or any therapeutic purpose. These substances must not be used in humans, animals, or for any diagnostic or clinical application. The seller assumes no liability for any misuse, adverse events, or regulatory violations arising from the purchase, handling, or distribution of these products.
